Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A peek into the atomic details of thalidomide's clinical effects

After being used in the 1950s to treat morning sickness in pregnant women, with devastating effects, thalidomide and its derivatives (lenalidomide and pomalidomide) are now widely used in cancer therapy. New structural work from two groups gives insights into the basis for the teratogenicity and other clinical effects of these drugs.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Structure of DNA damage–binding protein (DDB1) and Cereblon (CRBN).

Accession codes

Accessions

Protein Data Bank

References

  1. Lenz, W., Pfeiffer, R.A., Kosenow, W. & Hayman, D.J. Lancet 279, 45–46 (1962).

    Article  Google Scholar 

  2. McBride, W.G. Lancet 278, 1358 (1961).

    Article  Google Scholar 

  3. Melchert, M. & List, A. Int. J. Biochem. Cell Biol. 39, 1489–1499 (2007).

    Article  CAS  Google Scholar 

  4. Ali, I., Wani, W.A., Saleem, K. & Haque, A. Curr. Drug. Ther. 7, 13–23 (2012).

    Article  CAS  Google Scholar 

  5. Greenstone, G.T. B. C. Med. J. 53, 230–233 (2011).

    Google Scholar 

  6. Chamberlain, P.P. et al. Nat. Struct. Mol. Biol. 21, 803–809 (2014).

    Article  CAS  Google Scholar 

  7. Fischer, E.S. et al. Nature 512, 49–53 (2014).

    Article  CAS  Google Scholar 

  8. Ito, T. et al. Science 327, 1345–1350 (2010).

    Article  CAS  Google Scholar 

  9. Angers, S. et al. Nature 443, 590–593 (2006).

    Article  CAS  Google Scholar 

  10. Lee, J. & Zhou, P. Mol. Cell 26, 775–780 (2007).

    Article  CAS  Google Scholar 

  11. Lu, G. et al. Science 343, 305–309 (2014).

    Article  CAS  Google Scholar 

  12. Krönke, J. et al. Science 343, 301–305 (2014).

    Article  Google Scholar 

  13. Merkenschlager, M. FEBS Lett. 584, 4910–4914 (2010).

    Article  CAS  Google Scholar 

  14. Capdevila, J., Tsukui, T., Esteban, C.R., Zappavigna, V. & Belmonte, J.C.I. Mol. Cell 4, 839–849 (1999).

    Article  CAS  Google Scholar 

  15. Cecconi, F., Proetzel, G., Alvarez-Bolado, G., Jay, D. & Gruss, P. Dev. Dyn. 210, 184–190 (1997).

    Article  CAS  Google Scholar 

  16. Zhang, X. Genes Dev. 16, 2097–2107 (2002).

    Article  CAS  Google Scholar 

  17. Kühlbrandt, W. Science 343, 1443–1444 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Dikic.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bhogaraju, S., Dikic, I. A peek into the atomic details of thalidomide's clinical effects. Nat Struct Mol Biol 21, 739–740 (2014). https://doi.org/10.1038/nsmb.2882

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nsmb.2882

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing